NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer (Q46866288)

26 December 2017

title

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer (English)

1 reference

26 December 2017

Erb-b2 receptor tyrosine kinase 2

main subject

1 reference

1

1 reference

26 December 2017

author name string

Thibault Verjat

2

1 reference

26 December 2017

Malick Paye

3

1 reference

26 December 2017

Anne-Claire Servanton

4

1 reference

26 December 2017

Jean Grenier

5

1 reference

26 December 2017

Philippe Leissner

6

1 reference

26 December 2017

Bruno Mougin

7

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

26 December 2017

volume

44

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

3-12

1 reference

26 December 2017

Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Current diagnostic methods of HER-2/neu detection in breast cancer with special regard to real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Relative Quantification of ERBB2 mRNA in Invasive Duct Carcinoma of the Breast: Correlation with ERBB-2 Protein Expression and ERBB2 Gene Copy Number

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Nucleic acid sequence-based amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Evaluation of HER2/neu status by real-time quantitative PCR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

Estrogen and progesterone receptor mrna levels in primary breast cancer: Association with patient survival and other clinical and tumor features

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.002

21 January 2018

Identifiers

DOI

10.1515/CCLM.2006.002

1 reference

26 December 2017

1 reference

26 December 2017